Application 204782

Type
ANDA
Sponsor
PERRIGO R AND D

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDECALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDETABLET, CHEWABLE;ORAL800MG;10MG;165MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A204782-001FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDECALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE800MG;10MG;165MGTABLET, CHEWABLE / ORAL2016-08-29

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A204782-001FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE800MG;10MG;165MGTABLET, CHEWABLE / ORAL2016-08-293a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A204782-001FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE800MG;10MG;165MGTABLET, CHEWABLE / ORAL2016-08-29f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A204782-001FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE800MG;10MG;165MGTABLET, CHEWABLE / ORAL2016-08-29e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A204782-001FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE800MG;10MG;165MGTABLET, CHEWABLE / ORAL2016-08-29cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A204782-001FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE800MG;10MG;165MGTABLET, CHEWABLE / ORAL2016-08-29a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
62011-0352health mart dual action completeFamotidine, Calcium carbonate, Magnesium hydroxideStrategic Sourcing Services LLCANDACurrent
69842-802acid reducer plus antacidFamotidine, Calcium carbonate, Magnesium hydroxideCVS PharmacyANDACurrent
69842-802acid reducer plus antacidFamotidine, Calcium carbonate, Magnesium hydroxideCVS PharmacyANDACurrent
70000-0316leader acid reducer completeFamotidine, calcium carbonate, magnesium hydroxideCardinal Health 110, LLC. dba LeaderANDACurrent
70000-0316leader acid reducer completeFamotidine, calcium carbonate, magnesium hydroxideCardinal HealthANDACurrent